Revvity (RVTY)

NYSE Health Care Health Care Equipment S&P 500

$155.11

+4.28 (+2.84%)

Close of Nov 06, 2026 · end-of-day data

Source: Revvity's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2023	FY2024	FY2025
Revenue	$2.12B	$2.26B	$2.78B	$2.88B	$2.66B	$3.83B	$3.31B	$2.75B	$2.76B	$2.86B
Cost of revenue	$664.80M	$708.68M	$1.44B	—	—	—	—	—	—	—
Gross profit	$1.01B	$1.07B	$1.34B	$1.40B	$2.11B	$2.43B	$1.99B	—	—	—
Research & development	$124.18M	$139.46M	$194.00M	$189.34M	$146.44M	$200.34M	$221.62M	$216.58M	$196.84M	$215.84M
Selling, general & admin	$590.47M	$626.02M	$811.91M	$815.32M	$716.47M	$975.19M	$1.03B	$1.02B	$994.07M	$991.89M
Operating income	$294.58M	$295.62M	$323.88M	$361.97M	$867.27M	$1.26B	$742.70M	$300.56M	$346.74M	$356.63M
Interest expense	$41.53M	$43.94M	$66.98M	$63.63M	$49.71M	—	$103.95M	$98.81M	$96.28M	$92.19M
Pre-tax income	$244.07M	$296.72M	$257.68M	$237.14M	$800.07M	$1.20B	$651.84M	$182.98M	$316.13M	$268.28M
Income tax	$28.36M	$139.83M	$20.21M	$9.39M	$169.51M	$314.15M	$139.16M	$3.47M	$33.05M	$28.39M
Net income	$234.30M	$292.63M	$237.93M	$227.56M	$727.89M	$943.16M	$569.18M	$693.09M	$270.38M	$241.20M
EBITDA	$394.55M	$400.62M	$504.47M	$576.00M	$1.07B	$1.57B	$1.17B	$732.33M	$774.59M	$761.98M
EPS (basic)	$2.14	$2.67	$2.15	$2.06	$6.52	$8.12	$4.51	$5.56	$2.21	$2.07
EPS (diluted)	$2.12	$2.64	$2.13	$2.04	$6.49	$8.08	$4.50	$5.55	$2.20	$2.07
Diluted shares	110.31M	110.86M	111.53M	111.50M	112.08M	116.67M	126.43M	124.81M	122.82M	116.59M
Gross margin	47.9%	47.6%	48.3%	48.4%	79.2%	63.6%	60.1%	—	—	—
Operating margin	13.9%	13.1%	11.7%	12.6%	32.6%	32.9%	22.4%	10.9%	12.6%	12.5%
Net margin	11.1%	13.0%	8.6%	7.9%	27.3%	24.6%	17.2%	25.2%	9.8%	8.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2023	FY2024	FY2025
Cash & equivalents	$359.26M	$202.13M	$163.11M	$191.88M	$387.05M	$603.32M	$454.36M	$913.16M	$1.16B	$919.86M
Short-term investments	—	—	—	—	—	—	$0	$689.92M	$0	—
Receivables	$425.59M	$552.30M	$632.67M	$725.18M	$1.16B	$707.94M	$612.78M	$632.81M	$632.40M	$744.67M
Inventory	$246.85M	$351.68M	$338.35M	$356.94M	$514.57M	$425.89M	$405.46M	$428.06M	$367.59M	$379.50M
Total current assets	$1.19B	$1.20B	$1.23B	$1.37B	$2.24B	$2.44B	$3.29B	$3.00B	$2.35B	$2.24B
Goodwill	$2.25B	$3.00B	$2.95B	$3.11B	$2.64B	$6.63B	$6.48B	$6.53B	$6.46B	$6.61B
Total assets	$4.28B	$6.09B	$5.98B	$6.54B	$7.96B	$15.00B	$14.13B	$13.56B	$12.39B	$12.17B
Total current liabilities	$603.36M	$950.90M	$771.63M	$762.83M	$1.65B	$1.21B	$1.54B	$1.45B	$653.10M	$1.33B
Short-term debt	$1.17M	$217.31M	$14.86M	$9.97M	$381.19M	$4.24M	$470.93M	$721.87M	$242.00K	$588.83M
Long-term debt	$1.05B	$1.79B	$1.88B	$2.06B	$1.61B	$4.98B	$3.92B	$3.18B	$3.15B	$2.63B
Total debt	$1.05B	$2.01B	$1.89B	$2.07B	$1.99B	$4.98B	$4.39B	$3.90B	$3.15B	$3.22B
Total liabilities	$2.12B	$3.59B	$3.39B	$3.72B	$4.22B	$7.86B	$6.75B	$5.69B	$4.73B	$4.92B
Shareholders' equity	$2.15B	$2.50B	$2.58B	$2.81B	$3.74B	$7.14B	$7.38B	$7.87B	$7.67B	$7.25B

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2023	FY2024	FY2025
Operating cash flow	$350.62M	$288.45M	$311.04M	$363.47M	$892.18M	$1.41B	$679.81M	$91.27M	$628.30M	$582.93M
Capital expenditures	$31.70M	$39.09M	$93.25M	$76.33M	$63.63M	$86.02M	$85.63M	$81.37M	$86.65M	$73.52M
Free cash flow	$318.91M	$249.36M	$217.78M	$287.14M	$828.54M	$1.32B	$594.18M	$9.90M	$541.65M	$509.41M
Investing cash flow	-$83.88M	-$1.27B	-$159.86M	-$487.57M	-$504.50M	-$4.11B	-$132.85M	$1.31B	$776.16M	-$17.35M
Financing cash flow	-$115.01M	$782.24M	-$179.23M	-$150.13M	-$202.87M	$2.94B	-$661.80M	-$947.12M	-$1.13B	-$857.52M
Dividends paid	$30.80M	$30.79M	$31.01M	$31.06M	$31.21M	$32.37M	$35.34M	$34.97M	$34.45M	$32.80M
Share buybacks	$151.80M	$3.83M	$57.45M	$6.31M	$6.94M	$73.07M	$80.64M	$388.88M	$369.58M	$820.82M
Stock-based compensation	$17.16M	$25.42M	$28.77M	$31.51M	$26.90M	$29.68M	$51.52M	$41.41M	$37.81M	$22.85M
Depreciation & amortization	$99.97M	$105.00M	$180.59M	$214.03M	$201.65M	$311.44M	$427.00M	$431.77M	$427.85M	$405.34M

Income statement

quarters · USD

Quarter ended	Oct 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Apr 2026	Jul 2026
Revenue	$670.74M	$695.90M	$649.92M	$691.68M	$684.05M	$729.37M	$664.76M	$720.28M	$698.95M	$772.06M	$711.12M	$729.69M
Cost of revenue	$298.22M	—	$294.87M	$306.18M	$299.23M	—	$289.22M	$327.73M	$324.35M	—	$323.46M	$312.82M
Gross profit	$372.52M	—	$355.05M	$385.51M	$384.82M	—	$375.55M	$392.56M	$374.60M	—	$387.65M	$416.87M
Research & development	$53.04M	$49.60M	$50.36M	$48.13M	$49.14M	$49.21M	$53.60M	$53.27M	$50.80M	$58.18M	$57.89M	$48.97M
Selling, general & admin	$250.25M	$256.72M	$260.57M	$251.65M	$237.52M	$244.33M	$249.72M	$248.53M	$241.91M	$251.73M	$253.88M	$278.58M
Operating income	$69.23M	$77.16M	$44.12M	$85.72M	$98.15M	$118.75M	$72.23M	$90.76M	$81.90M	$111.75M	$75.89M	$89.32M
Interest expense	$25.49M	$24.58M	$24.40M	$24.72M	$24.38M	$22.78M	$22.96M	$22.94M	$22.77M	$23.51M	$24.72M	$22.99M
Pre-tax income	$50.60M	$31.38M	$34.55M	$86.66M	$100.36M	$94.56M	$52.38M	$68.65M	$55.69M	$91.56M	$49.99M	$63.53M
Income tax	$18.13M	-$32.19M	$5.85M	$14.06M	$6.97M	$6.17M	$10.71M	$13.43M	$8.46M	-$4.21M	$9.10M	$10.05M
Net income	$9.50M	$78.56M	$26.01M	$55.36M	$94.37M	$94.64M	$42.24M	$53.95M	$46.65M	$98.36M	$40.72M	$51.82M
EBITDA	$177.49M	$182.73M	$151.92M	$193.07M	$205.82M	$223.78M	$169.65M	$193.54M	$183.96M	$214.83M	$180.94M	$191.35M
EPS (basic)	$0.08	$0.65	$0.21	$0.45	$0.77	$0.78	$0.35	$0.46	$0.40	$0.86	$0.36	$0.47
EPS (diluted)	$0.08	$0.65	$0.21	$0.45	$0.77	$0.78	$0.35	$0.46	$0.40	$0.86	$0.36	$0.47
Diluted shares	124.20M	-523.00K	123.54M	123.48M	123.03M	-514.00K	120.23M	117.54M	115.46M	-1.14M	111.88M	111.63M
Gross margin	55.5%	—	54.6%	55.7%	56.3%	—	56.5%	54.5%	53.6%	—	54.5%	57.1%
Operating margin	10.3%	11.1%	6.8%	12.4%	14.3%	16.3%	10.9%	12.6%	11.7%	14.5%	10.7%	12.2%
Net margin	1.4%	11.3%	4.0%	8.0%	13.8%	13.0%	6.4%	7.5%	6.7%	12.7%	5.7%	7.1%

Balance sheet

quarters · USD

Quarter ended	Oct 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Apr 2026	Jul 2026
Cash & equivalents	$1.14B	$913.16M	$998.08M	$1.25B	$1.23B	$1.16B	$1.14B	$991.85M	$931.39M	$919.86M	$860.32M	$1.02B
Short-term investments	$292.97M	$689.92M	$697.33M	$706.07M	$0	$0	—	—	—	—	—	—
Receivables	$644.57M	$632.81M	$588.97M	$597.44M	$602.14M	$632.40M	$617.42M	$661.14M	$680.26M	$744.67M	$691.38M	$709.17M
Inventory	$435.70M	$428.06M	$414.03M	$401.43M	$404.57M	$367.59M	$381.31M	$388.47M	$379.92M	$379.50M	$387.50M	$378.50M
Total current assets	$2.91B	$3.00B	$3.06B	$3.16B	$2.45B	$2.35B	$2.32B	$2.24B	$2.14B	$2.24B	$2.13B	$2.30B
Goodwill	$6.47B	$6.53B	$6.50B	$6.50B	$6.56B	$6.46B	$6.51B	$6.61B	$6.60B	$6.61B	$6.61B	$6.61B
Total assets	$13.42B	$13.56B	$13.43B	$13.42B	$12.77B	$12.39B	$12.36B	$12.36B	$12.14B	$12.17B	$12.00B	$12.05B
Total current liabilities	$1.45B	$1.45B	$1.37B	$1.39B	$687.94M	$653.10M	$648.19M	$671.81M	$1.22B	$1.33B	$1.24B	$1.28B
Short-term debt	$727.54M	$721.87M	$711.44M	$711.41M	$1.04M	$242.00K	$242.00K	$230.00K	$583.84M	$588.83M	$575.83M	$572.16M
Long-term debt	$3.15B	$3.18B	$3.16B	$3.16B	$3.19B	$3.15B	$3.17B	$3.21B	$2.63B	$2.63B	$2.63B	$2.63B
Total debt	$3.88B	$3.90B	$3.88B	$3.87B	$3.19B	$3.15B	$3.17B	$3.21B	$3.21B	$3.22B	$3.21B	$3.21B
Total liabilities	$5.73B	$5.69B	$5.59B	$5.55B	$4.85B	$4.73B	$4.72B	$4.81B	$4.76B	$4.92B	$4.81B	$4.82B
Shareholders' equity	$7.69B	$7.87B	$7.85B	$7.87B	$7.92B	$7.67B	$7.64B	$7.56B	$7.38B	$7.25B	$7.18B	$7.23B

Cash flow

quarters · USD

Quarter ended	Oct 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Apr 2026	Jul 2026
Operating cash flow	-$33.48M	$196.61M	$147.56M	$158.62M	$147.88M	$174.23M	$128.16M	$134.32M	$138.50M	$181.96M	$115.23M	$191.94M
Capital expenditures	$22.36M	$24.12M	$17.84M	$22.03M	$22.32M	$24.45M	$15.98M	$18.87M	$18.50M	$20.17M	$19.77M	$11.07M
Free cash flow	-$55.84M	$172.50M	$129.72M	$136.59M	$125.57M	$149.78M	$112.17M	$115.45M	$120.00M	$161.79M	$95.45M	$180.87M
Investing cash flow	$434.87M	-$414.81M	-$18.18M	$121.49M	$690.18M	-$17.33M	-$6.38M	-$9.49M	$18.97M	-$20.45M	-$78.27M	-$3.50M
Financing cash flow	-$586.05M	-$19.61M	-$35.01M	-$26.50M	-$873.74M	-$192.99M	-$163.66M	-$302.48M	-$215.07M	-$176.31M	-$88.89M	-$23.16M
Dividends paid	$8.69M	$8.64M	$8.64M	$8.64M	$8.63M	$8.54M	$8.43M	$8.28M	$8.13M	$7.96M	$7.84M	$7.81M
Share buybacks	$110.72M	$4.87M	$10.76M	$19.55M	$154.11M	$185.16M	$153.59M	$293.91M	$205.03M	$168.28M	$86.50M	$15.99M
Stock-based compensation	$10.70M	$7.18M	$11.69M	$10.53M	$10.54M	$5.05M	$7.73M	$10.13M	$9.05M	-$4.07M	$8.71M	$10.73M
Depreciation & amortization	$108.26M	$105.57M	$107.80M	$107.34M	$107.67M	$105.03M	$97.42M	$102.78M	$102.06M	$103.08M	$105.06M	$102.04M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.